|
 | Up a level |
Kaypee, Stephanie and Sudarshan, Deepthi and Shanmugam, Muthu K and Mukherjee, Debanjan and Sethi, Gautam and Kundu, Tapas K (2016) Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics. In: PHARMACOLOGY & THERAPEUTICS, 162 . pp. 98-119.
Selvi, Ruthrotha B and Swaminathan, Amrutha and Chatterjee, Snehajyoti and Shanmugam, Muthu K and Li, Feng and Ramakrishnan, Gowsica B and Siveen, Kodappully Sivaraman and Chinnathambi, Arunachalam and Zayed, M. Emam and Alharbi, Sulaiman Ali and Basha, Jeelan and Bhat, Akshay and Vasudevan, Madavan and Dharmarajan, Arunasalam and Sethi, Gautam and Kundu, Tapas K (2016) Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model. In: ONCOTARGET, 6 (41). pp. 43806-43818.
Srivastava, Sandeep and Bhowmick, Krishanu and Chatterjee, Snehajyoti and Basha, Jeelan and Kundu, Tapas K and Dhar, Suman K (2014) Histone H3K9 acetylation level modulates gene expression and may affect parasite growth in human malaria parasite Plasmodium falciparum. In: FEBS JOURNAL, 281 (23). pp. 5265-5278.
